154 related articles for article (PubMed ID: 38086335)
21. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
22. Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms.
Alcala N; Voegele C; Mangiante L; Sexton-Oates A; Clevers H; Fernandez-Cuesta L; Dayton TL; Foll M
Gigascience; 2024 Jan; 13():. PubMed ID: 38451475
[TBL] [Abstract][Full Text] [Related]
23. BRAF
Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
[TBL] [Abstract][Full Text] [Related]
24. Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
De Divitiis C; von Arx C; Grimaldi AM; Cicala D; Tatangelo F; Arcella A; Romano GM; Simeone E; Iaffaioli RV; Ascierto PA; Tafuto S;
J Transl Med; 2016 May; 14(1):113. PubMed ID: 27142424
[TBL] [Abstract][Full Text] [Related]
25. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
Klöppel G
Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
[TBL] [Abstract][Full Text] [Related]
26. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
[TBL] [Abstract][Full Text] [Related]
27. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
Sun TY; Hendifar A; Padda SK
Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
[TBL] [Abstract][Full Text] [Related]
28. An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets.
Griger J; Widholz SA; Jesinghaus M; de Andrade Krätzig N; Lange S; Engleitner T; Montero JJ; Zhigalova E; Öllinger R; Suresh V; Winkler W; Lier S; Baranov O; Trozzo R; Ben Khaled N; Chakraborty S; Yu J; Konukiewitz B; Steiger K; Pfarr N; Rajput A; Sailer D; Keller G; Schirmacher P; Röcken C; Fagerstedt KW; Mayerle J; Schmidt-Supprian M; Schneider G; Weichert W; Calado DP; Sommermann T; Klöppel G; Rajewsky K; Saur D; Rad R
Cancer Cell; 2023 Jul; 41(7):1327-1344.e10. PubMed ID: 37352862
[TBL] [Abstract][Full Text] [Related]
29. Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions.
Detjen K; Hammerich L; Özdirik B; Demir M; Wiedenmann B; Tacke F; Jann H; Roderburg C
Neuroendocrinology; 2021; 111(3):217-236. PubMed ID: 32615560
[TBL] [Abstract][Full Text] [Related]
30. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.
Shafi S; Hu Y; Parwani AV; Ding Q; Li Z
Breast Cancer Res Treat; 2022 Dec; 196(3):463-469. PubMed ID: 36260193
[TBL] [Abstract][Full Text] [Related]
32. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
[No Abstract] [Full Text] [Related]
33. Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Puliafito I; Chillari F; Russo A; Cantale O; Sciacca D; Castorina L; Colarossi C; Franchina T; Vitale MP; Ricciardi GRR; Adamo V; Esposito F; Giuffrida D
Front Endocrinol (Lausanne); 2023; 14():1065599. PubMed ID: 36793289
[TBL] [Abstract][Full Text] [Related]
34. [Advances of pathological diagnosis and molecular pathology of lung neuroendocrine neoplasms].
Wu JH; Zhu YL; Wang HY; Liu YH; Lin DM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):109-115. PubMed ID: 38281776
[TBL] [Abstract][Full Text] [Related]
35. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract][Full Text] [Related]
36. Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine Neoplasia.
Weber MM; Fottner C
Oncol Res Treat; 2018; 41(5):306-312. PubMed ID: 29742518
[TBL] [Abstract][Full Text] [Related]
37. Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.
Dijkstra KK; van den Berg JG; Weeber F; van de Haar J; Velds A; Kaing S; Peters DDGC; Eskens FALM; de Groot DA; Tesselaar MET; Voest EE
Front Endocrinol (Lausanne); 2021; 12():627819. PubMed ID: 33776923
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies.
Kawasaki K; Rekhtman N; Quintanal-Villalonga Á; Rudin CM
Nat Rev Clin Oncol; 2023 Jan; 20(1):16-32. PubMed ID: 36307533
[TBL] [Abstract][Full Text] [Related]
39. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
40. Neuroendocrine neoplasms of the esophagus and stomach.
Mastracci L; Rindi G; Grillo F; Solcia E; Campora M; Fassan M; Parente P; Vanoli A; La Rosa S
Pathologica; 2021 Feb; 113(1):5-11. PubMed ID: 33686305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
